Prolonged Response Induced by Single Agent Vemurafenib in a

BRAF central nervous system tumor ganglioglioma safety spinal cord tumor regression vemurafenib

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 07 12 2018
accepted: 04 03 2019
entrez: 16 4 2019
pubmed: 16 4 2019
medline: 16 4 2019
Statut: epublish

Résumé

Spinal ganglioglioma is a rare low-grade, slow-growing tumor of the central nervous system affecting mostly children and young adults. After surgery, some patients show tumor recurrence and/or malignant transformation. Gangliogliomas harbor molecular deficiencies such as mutations in the B-rapidly accelerated fibrosarcoma (

Identifiants

pubmed: 30984614
doi: 10.3389/fonc.2019.00177
pmc: PMC6448025
doi:

Types de publication

Case Reports

Langues

eng

Pagination

177

Références

J Clin Neurosci. 2004 Feb;11(2):199-203
pubmed: 14732385
J Neurooncol. 2004 May;68(1):71-7
pubmed: 15174523
Cancer. 2004 Jul 1;101(1):146-55
pubmed: 15222000
Acta Neuropathol. 2005 Feb;109(2):207-10
pubmed: 15791479
Clin Neurol Neurosurg. 2006 Dec;108(8):761-7
pubmed: 16219416
Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):244-7
pubmed: 17045420
Neuropathology. 2007 Oct;27(5):463-7
pubmed: 18018481
Clin Radiol. 2008 Jan;63(1):80-91
pubmed: 18068794
J Clin Invest. 2008 May;118(5):1739-49
pubmed: 18398503
Spinal Cord. 2009 Jan;47(1):87-90
pubmed: 18560374
Cancer. 2008 Dec 15;113(12):3355-63
pubmed: 18988291
J Neurosurg Pediatr. 2009 Jun;3(6):461-6
pubmed: 19485728
Cancer. 2010 Jan 15;116(2):432-42
pubmed: 19908258
Neuro Oncol. 2010 Jul;12(7):621-30
pubmed: 20156809
Acta Neuropathol. 2011 Mar;121(3):397-405
pubmed: 21274720
Brain Pathol. 2011 Sep;21(5):564-74
pubmed: 21314850
Lancet Oncol. 2011 Jun;12(6):583-93
pubmed: 21474379
N Engl J Med. 2011 Jun 30;364(26):2507-16
pubmed: 21639808
Clin Cancer Res. 2011 Dec 15;17(24):7595-604
pubmed: 22038996
J Neurosurg. 2012 Nov;117(5):825-30
pubmed: 22957524
J Clin Oncol. 2013 Apr 1;31(10):e159-60
pubmed: 23358987
Clin Exp Dermatol. 2013 Mar;38(2):222-3
pubmed: 23397951
Acta Neuropathol. 2013 Jun;125(6):891-900
pubmed: 23435618
Brain Pathol. 2013 Sep;23(5):574-83
pubmed: 23442159
Acta Neuropathol. 2013 Jun;125(6):901-10
pubmed: 23609006
J Neurooncol. 2013 Sep;114(2):237-40
pubmed: 23756728
J Neurooncol. 2014 Jan;116(1):135-43
pubmed: 24132615
Eur J Cancer. 2014 Feb;50(3):611-21
pubmed: 24295639
Neuro Oncol. 2014 Mar;16(3):409-13
pubmed: 24305706
Pediatr Blood Cancer. 2014 Jun;61(6):1101-3
pubmed: 24375920
J Clin Oncol. 2014 Oct 10;32(29):e98-e100
pubmed: 24516030
Pediatr Dermatol. 2015 Jan-Feb;32(1):153-4
pubmed: 24602192
Neurosurgery. 2014 Jul;75(1):37-42
pubmed: 24625425
BMC Cancer. 2014 Apr 12;14:258
pubmed: 24725538
Pediatr Blood Cancer. 2014 Nov;61(11):2099-100
pubmed: 24821190
Ther Adv Med Oncol. 2014 Nov;6(6):262-6
pubmed: 25364391
J Transl Med. 2014 Dec 19;12:356
pubmed: 25524464
Neurosurgery. 2015 Mar;76(3):313-9; discussion 319; quiz 319-20
pubmed: 25603107
Neuropathology. 2015 Dec;35(6):603-5
pubmed: 26073619
Am J Surg Pathol. 2016 Feb;40(2):279-84
pubmed: 26414224
Pediatr Blood Cancer. 2016 Mar;63(3):541-3
pubmed: 26579623
J Clin Imaging Sci. 2015 Sep 30;5:53
pubmed: 26605127
CNS Oncol. 2016;5(1):27-9
pubmed: 26680369
Hum Pathol. 2016 Mar;49:107-13
pubmed: 26826417
J Clin Neurosci. 2016 Aug;30:65-70
pubmed: 27083133
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
J Natl Compr Canc Netw. 2016 Nov;14(11):1345-1350
pubmed: 27799506
Neurology. 2017 Mar 28;88(13):1291-1293
pubmed: 28235815
Brain Behav. 2017 Feb 10;7(3):e00641
pubmed: 28293477
Acta Neuropathol Commun. 2017 May 15;5(1):38
pubmed: 28506301
Mol Neurobiol. 2018 May;55(5):3718-3724
pubmed: 28534272
J Clin Neurosci. 2017 Oct;44:34-46
pubmed: 28687443
J Clin Oncol. 2017 Sep 1;35(25):2934-2941
pubmed: 28727518
J Neurosurg. 2018 Sep;129(3):593-597
pubmed: 28960151
J Clin Neurosci. 2017 Dec;46:50-57
pubmed: 28986151
Oncol Rep. 2017 Dec;38(6):3291-3296
pubmed: 29039591
J Clin Oncol. 2018 Jan 1;36(1):96
pubmed: 29140771
J Neurooncol. 2018 May;137(3):667-669
pubmed: 29335912
Pediatr Blood Cancer. 2018 May;65(5):e26969
pubmed: 29380516
Clin Neuropathol. 2018 Mar/Apr;37 (2018)(2):53-63
pubmed: 29393845
Acta Neuropathol. 2018 Apr;135(4):639-642
pubmed: 29497819
J Magn Reson Imaging. 2018 May 7;:null
pubmed: 29734497
Acta Neuropathol Commun. 2018 Jun 7;6(1):47
pubmed: 29880043
J Neurooncol. 2018 Sep;139(3):739-747
pubmed: 29882043
JAMA Oncol. 2018 Oct 1;4(10):1382-1388
pubmed: 30073321
Neurology. 2018 Sep 11;91(11):523-525
pubmed: 30120137
J Clin Oncol. 2018 Oct 23;:JCO2018789990
pubmed: 30351999
Front Oncol. 2018 Nov 14;8:526
pubmed: 30488019
Acta Neurochir (Wien). 1993;125(1-4):52-7
pubmed: 8122557
J Neurosurg. 1993 Dec;79(6):867-73
pubmed: 8246055
AJNR Am J Neuroradiol. 1998 May;19(5):879-87
pubmed: 9613504

Auteurs

Louis Garnier (L)

Department of Medical Oncology, University Hospital of Besançon, Besançon, France.

François Ducray (F)

Department of Neuro-Oncology, Hospices Civils de Lyon, Lyon, France.

Clotilde Verlut (C)

Department of Neurology, University Hospital of Besançon, Besançon, France.

Marcella-Ionela Mihai (MI)

Department of Pathology, University Hospital of Besançon, Besançon, France.

Françoise Cattin (F)

Department of Radiology, University Hospital of Besançon, Besançon, France.

Antoine Petit (A)

Department of Neurosurgery, University Hospital of Besançon, Besançon, France.

Elsa Curtit (E)

Department of Medical Oncology, University Hospital of Besançon, Besançon, France.

Classifications MeSH